HB3710 EngrossedLRB103 27320 CPF 53691 b

1    AN ACT concerning health.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 1. Short title. This Act may be cited as the
5Alternative Protein Innovation Task Force Act.
6    Section 5. Definitions. As used in this Act:
7    "Alternative proteins" means proteins created from
8plant-based, fermented, cell-cultured inputs and processes to
9create foods that share sensory characteristics with
10conventional meat and dairy.
11    "Cultivated meat" means meat that is produced in a
12bioreactor from animal cells using a cell cultivation process.
13    "Fermented protein" means a protein that is made from
14traditional fermentation, biomass fermentation, or precision
16    "Plant-based protein" means a protein that is produced
17directly from a plant.
18    Section 10. Alternative Protein Innovation Task Force. The
19Alternative Protein Innovation Task Force is established for
20the purposes of investigating and studying alternative
21proteins and developing a master plan of recommendations for
22fostering the appropriate expansion of protein innovation and



HB3710 Engrossed- 2 -LRB103 27320 CPF 53691 b

1the alternative protein industry in the State. The Task Force
2shall study how the State can best support the growing
3alternative protein industry in the State. The Task Force
4shall: (i) examine the potential economic development benefits
5and job creation potential of the plant-based protein,
6cultivated meat, and fermented protein industries in the
7State; (ii) identify the environmental benefits of alternative
8proteins; (iii) examine how alternative proteins can
9strengthen the State's food resilience; (iv) assess how
10alternative proteins can improve individual health, public
11health, and food security in the State; and (v) identify ways
12the State can foster the growth of the emerging alternative
13protein industry, including by reviewing past efforts made to
14support the broader biotech and life science industries.
15    Section 15. Membership; appointments; meeting.
16    (a) The Alternative Protein Innovation Task Force shall
17consist of the following members:
18        (1) one member of the Senate, who shall be appointed
19    by the President of the Senate and shall serve as co-chair
20    of the Task Force;
21        (2) one member of the Senate, who shall be appointed
22    by the Minority Leader of the Senate;
23        (3) one member of the House of Representatives, who
24    shall be appointed by the Speaker of the House of
25    Representatives and shall serve as co-chair of the Task



HB3710 Engrossed- 3 -LRB103 27320 CPF 53691 b

1    Force;
2        (4) one member of the House of Representatives, who
3    shall be appointed by the Minority Leader of the House of
4    Representatives;
5        (5) the Secretary of Commerce and Economic Opportunity
6    or the Secretary's designee;
7        (6) the Director of Agriculture or the Director's
8    designee;
9        (7) 2 members who are appointed by the Director of
10    Agriculture and are commercial producers of agricultural
11    commodities; and
12        (8) 7 members who are appointed by the Governor. Of
13    the members appointed by the Governor, 2 members shall be
14    engaged in academic or scientific research on alternative
15    protein development at a State college or university; one
16    member shall be engaged in the private sector research and
17    development of alternative proteins; one member shall be
18    an academic expert in food security issues of the State;
19    one member shall be a representative of a nonprofit
20    organization dedicated to the development and
21    accessibility of alternative proteins; one member shall be
22    a representative of the State's agricultural biotechnology
23    industry; and one member shall be the president of the
24    Illinois Biotechnology Industry Organization or the
25    organization's designee.
26    (b) Members of the Task Force shall not receive



HB3710 Engrossed- 4 -LRB103 27320 CPF 53691 b

1compensation for their services to the Task Force.
2    (c) All appointments shall be made not later than 30 days
3after the effective date of this Act.
4    (d) The co-chairs of the Task Force shall schedule no
5fewer than 4 meetings of the Task Force, including not less
6than one public hearing. The co-chairs shall convene the first
7meeting of the Task Force within 60 days after the effective
8date of this Act.
9    Section 20. Report.
10    (a) The Task Force shall study and analyze the potential
11benefits of alternative proteins and shall address in its
13        (1) the job growth potential of the alternative
14    protein industry in the State as demand for protein
15    continues to grow;
16        (2) how plant-based protein, fermented proteins, and
17    cultivated meat can yield environmental benefits;
18        (3) how the State can support new and emerging
19    companies in this sector and what pressing challenges the
20    industry currently faces;
21        (4) policy options the State can consider taking to
22    address the needs of the alternative protein industry;
23        (5) actions that can be taken to facilitate the growth
24    of the alternative protein industry; and
25        (6) any other topic that the Task Force may choose to



HB3710 Engrossed- 5 -LRB103 27320 CPF 53691 b

1    examine in relation to alternative proteins.
2    (b) The Task Force shall submit a report of its findings
3and recommendations to the General Assembly, together with
4drafts of proposed legislation necessary to carry out those
5recommendations, not later than December 31, 2023.
6    Section 99. Effective date. This Act takes effect upon
7becoming law.